Unstable angina and non-ST elevation myocardial infarction (Q37972109)

26 August 2017

title

Unstable angina and non-ST elevation myocardial infarction (English)

1 reference

26 August 2017

main subject

myocardial infarction

1 reference

1 reference

1

Eugene Braunwald

1 reference

26 August 2017

language of work or name

English

0 references

publication date

28 December 2011

1 reference

American Journal of Respiratory and Critical Care Medicine

26 August 2017

published in

1 reference

26 August 2017

volume

185

1 reference

26 August 2017

issue

9

1 reference

26 August 2017

page(s)

924-932

1 reference

The evolving epidemiology of acute coronary syndromes

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Corona

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

The Global Registry of Acute Coronary Events, 1999 to 2009--GRACE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Cytochrome p-450 polymorphisms and response to clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Early versus delayed, provisional eptifibatide in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Rivaroxaban in patients with a recent acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

A randomized trial of therapies for type 2 diabetes and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

Anticoagulation for ST-Segment Elevation Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201109-1745CI

10.1164/RCCM.201109-1745CI

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference